Longevity Research

{
  "result": " This tick, the mission architected a narrow, prioritized assault on the mTORC1–autophagy–inflammaging axis, selecting three converging lines of inquiry as the best route to establish the knowledge graph’s first verified causal relation. The centerpiece is a bid to connect genetic variation in *RPTOR* and *TSC2*—core mTORC1 regulatory nodes—to circulating IL-6 and high-sensitivity CRP through colocalized Mendelian randomization, while simultaneously planning primary human macrophage experiments to test whether mTORC1 perturbation couples TFEB/TFE3 nuclear translocation to NF-κB p65 phosphorylation and IL-6 secretion. Rather than yielding empirical discoveries, this cycle produced zero new findings and advanced four refined hypotheses, reflecting a deliberate decision to trade breadth for causal specificity; full cytokine panels, cancer subtype analyses, and broad multi-omics integration were deprioritized until the first edge is secured.\n\nThe mechanism under interrogation can be thought of as a molecular dimmer switch for cellular cleanup and inflammation. mTORC1 acts as a nutrient sensor that, when active, suppresses autophagy—the cell’s recycling program—by keeping transcription factors TFEB and TFE3 out of the nucleus. The mission hypothesizes that dialing down mTORC1 activity, either genetically through *RPTOR* or *TSC2* variation or pharmacologically with rapamycin, will release this brake, allowing TFEB/TFE3 to enter macrophage nuclei. This nuclear shift is proposed to suppress NF-κB p65 activation (specifically phosphorylation at Ser536), thereby turning down the production of IL-6 and CRP, two clinically familiar blood markers of chronic age-related inflammation. If true, the pathway would provide a genetically anchored, macrophage-specific explanation for how mTORC1 modulation could translate into reduced inflammaging in humans.\n\nAt this stage, the evidence strength for the specific *RPTOR*/*TSC2* → macrophage TFEB/TFE3 → NF-κB → IL-6/hs-CRP chain is purely hypothetical; no new in vitro, animal, or human data were generated this tick, and the knowledge graph holds 131 entities but zero verified relations. The recent literature intake consisted of high-level geroscience reviews and translational commentaries, which reinforce the general plausibility of targeting mTORC1 and inflammation to promote healthy aging but do not test the proposed causal chain. Preclinical animal studies robustly support lifespan extension and anti-inflammatory effects from mTORC1 inhibition, and human observational and GWAS literature links IL-6 and CRP to mortality and morbidity; however, the macrophage-specific autophagy-mediated mechanism remains an unvalidated model requiring the planned Mendelian randomization and human cell experiments.\n\nOutstanding questions center on instrument validity and mechanistic specificity: Do the *RPTOR* and *TSC2* cis-pQTL instruments truly influence IL-6 and CRP through macrophage autophagy rather than through metabolic pleiotropy in liver or adipose tissue? Can the colocalization probability exceed the stringent PP.H4 > 0.8 threshold needed for causal inference? Next tick, the swarm will attempt to execute the inverse-variance weighted Mendelian randomization, cross-reference instruments with macrophage eQTL atlases (e.g., Schmiedel immune QTL, GTEx spleen/whole blood), and map variant effects onto autophagy flux markers such as SQSTM1/p62 and LC3B-II. If the genetic architecture holds, the priority shifts to primary human monocyte-derived or iPSC-derived macrophages to quantify TFEB/TFE3 translocation, NF-κB p65 Ser536 phosphorylation, and secreted IL-6 under siRNA or rapamycin perturbation. Overall confidence in the broad direction—mTORC1 as a modulator of human inflammation—is moderate, grounded in decades of preclinical geroscience; confidence in the specific causal architecture proposed here remains low but tractable, contingent entirely on the successful execution of these next validation steps.\n\nThese findings are generated by an AI scanning published literature and should not be interpreted as medical advice.",
  "items_processed": 120,
  "findings": 0,
  "hypotheses": 4
}